Research
Hormonal
Phase 2 trials of retatrutide revealed weight reductions approaching 24.2% over 48 weeks.
Retatrutide may offer substantial weight loss benefits for individuals with obesity over a 48-week period.
StrongSupportsmedium confidence
Phase 2 trials of retatrutide revealed even more remarkable outcomes, with weight reductions approaching 24.2% over 48 weeks.
Why this rating
Based on the mention of phase 2 clinical trials.
Source
TIRZEPATIDE AND RETATRUTIDE IN THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS: CURRENT EVIDENCE AND FUTURE DIRECTIONS. A SYSTEMATIC REVIEW OF CURRENT LITERATURE
Rafał Bednarczyk et al. · International Journal of Innovative Technologies in Social Science · 2026
systematic_review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →